Live Breaking News & Updates on Edit

Stay informed with the latest breaking news from Edit on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Edit and stay connected to the pulse of your community

Team-BHP 2-Wheeler of the Year, 2023. Edit: It's the Royal Enfield Himalayan!

I guess that this shouldn't come as a surprise to any of the regulars in the Motorbikes section of our forum, but I voted for the Himalayan 450 as the TBHP 2 Wheeler of the Year, 2023. While there are

India , Japan , Japanese , Honda , Enfield-himalayan , Honda-transalp , Team , Bhp , 2 , Wheeler , Year

Team-BHP Car of the Year, 2023 | EDIT: It's the Toyota Innova Hycross

Though I cannot cast a vote as of now, if i could I would vote for the Hyundai Verna. The Verna is a complete package at the ~20L price segment and looks hot in black. It has even managed to take the

India , Muvs-mpvs , Verna-ioniq , Jimny-verna , Innova-hycross , Innova-crysta , Toyota-india , Team , Bhp , Car , Year

Mahindra Scorpio-N gets surprise crash test from ANCAP; to get rating in 2023. EDIT: Gets Zero Stars

According to a media report from Australia , the Mahindra Scorpio-N and MG 5 will have ANCAP safety ratings by the end of the year. Mahindra had earlier announced that they would wait until a mid-cycle

Australia , Australian , Carla-hoorweg , Mahindra-scorpio-n , Mahindra , Scorpio , N , Gets , Surprise , Crash , Test

Editas Medicine (NASDAQ:EDIT) Shares Gap Up on Analyst Upgrade

Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) gapped up before the market opened on Wednesday after Truist Financial raised their price target on the stock from $15.00 to $20.00. The stock had previously closed at $9.84, but opened at $10.38. Truist Financial currently has a buy rating on the stock. Editas Medicine shares last […]

Stifel-nicolaus , Jpmorgan-chase-co , Citigroup , Nasdaq , Cantor-fitzgerald , Editas-medicine-company-profile , Blackrock-inc , Marshall-wace , Editas-medicine-inc , Vanguard-group-inc , Editas-medicine , Get-free-report

Vertex stock heads for all-time high as non-opioid painkiller shows promise

Vertex Pharmaceuticals' stock was on track for an all-time high Wednesday after the company released new data on its experimental non-opioid pain medicine.

Liisa-bayko , Carmen-bozic , Vertex-pharmaceuticals-inc , Viatris-inc , Editas-medicine-inc , Drug-administration , Vertex-pharmaceuticals , Editas-medicine , Crispr-cas , Article-normal , Pharmaceuticals , Analgesics

Pixelmator Pro 3.5 Released With Full HDR Support

Pixelmator Pro 3.5 has been released, bringing full HDR support that lets you import, edit, and export HDR content, including HDR photos and videos taken with iPhone.

Mac-app , Pixelmator-pro , With-full , New-in-this-version , Apple-prores , Adobe-photoshop , Pro-display , Macbook-pro , Liquid-retina , Image-video , App-store

My VW Vento TSI DSG | Edit: 10 years and 83,000 km update on pg. 3

On November 30th, the car quietly entered its 10th year. No major updates to share post the mid-life refresh. Just wanted to document the event here. Odo is at 74k now. Glad that I did the upgrades

Kerala , India , Kannur , Karnataka , M-center , Service-center , Volkswagen , Vw-service-centers , Blaupunkt-philadelphia , Car-care , Quiet-period

Tesla pick-up truck plans confirmed EDIT: 'Cybertruck' unveiled!

Hate it or love it, but cant be ignored. Tesla Cybertruck up-close. https://www.youtube.com/watch?v=8Tg4...el=CyberOwners

Jason-camisa , Tesla , Pick , Up , Truck , Plans , Confirmed , Edit , Cybertruck , Unveiled , Tesla-pick-up-truck-plans-confirmed-edit-cybertruck-unveiled-

Head to Head Contrast: Innate Pharma (NASDAQ:IPHA) vs. Editas Medicine (NASDAQ:EDIT)

Editas Medicine (NASDAQ:EDIT – Get Free Report) and Innate Pharma (NASDAQ:IPHA – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, profitability, earnings, institutional ownership, analyst recommendations, valuation and dividends. Institutional & Insider Ownership 76.6% of Editas […]

Massachusetts , United-states , Cambridge , Cambridgeshire , United-kingdom , France , Novo-nordisk , Astrazeneca , Juno-therapeutics-inc , Allergan-pharmaceuticals-international , Editas-medicine-inc , Gengine-inc